Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Cagrilintide is a long acting amylin analog that regulates appetite, gastric emptying, and glucagon secretion to treat obesity and related metabolic disorders. There are 2 pathways cagrilintide works: #1 is the Amylin pathway GLP 1 receptor agonists and next generation incretin based medications: metabolic, cardiovascular, and renal benefits The Lancet Upcoming wave of hormone based therapies set to change field of diabetes, obesity care Mazdutide 10mg Loti Labs